Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Personalized Cancer Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT03361852
What this trial is testing

Personalized Neoantigen Cancer Vaccine + Pembrolizumab After Rituximab for Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
Dana-Farber Cancer Institute 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05309421
What this trial is testing

A Single Arm Trial Evaluating the Efficacy and Safety of EVX-01 in Combination With Pembrolizumab in Adults With Unresectable or Metastatic Melanoma

Who this might be right for
Melanoma Stage IVUnresectable Melanoma
Evaxion Biotech A/S 17
Testing effectiveness (Phase 2)Study completedNCT03633110
What this trial is testing

Safety, Tolerability, Immunogenicity, and Antitumor Activity of GEN-009 Adjuvanted Vaccine

Who this might be right for
Cutaneous MelanomaNon-small Cell Lung CancerSquamous Cell Carcinoma of the Head and Neck+2 more
Genocea Biosciences, Inc. 24
Early research (Phase 1)Active Not RecruitingNCT02950766
What this trial is testing

NeoVax Plus Ipilimumab in Renal Cell Carcinoma

Who this might be right for
Kidney Cancer
Patrick Ott, MD, PhD 19
Early research (Phase 1)Looking for participantsNCT05098210
What this trial is testing

Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Locally Advanced Cutaneous Melanoma+22 more
Fred Hutchinson Cancer Center 28
Testing effectiveness (Phase 2)Ended earlyNCT00510471
What this trial is testing

Personalized Active Immunotherapy (Vaccine Therapy) and Sargramostim Given After Standard of Care Treatment With Rituximab and Chemotherapy for Initial Treatment With Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Genitope Corporation
Not applicableAvailableNCT07612930
What this trial is testing

Expanded Access to PCNAT-01 for Patients With Resected Pancreatic Ductal Adenocarcinoma Following Surgical Resection and Adjuvant Therapy

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)
Anda Biopharmaceutical Development (Shenzhen) Co., Ltd.
Large-scale testing (Phase 3)Ended earlyNCT00126178
What this trial is testing

Clinical Trial Studying a Personalized Cancer Vaccine in Patients With Non-metastatic Kidney Cancer

Who this might be right for
Kidney CancerRenal Cell Carcinoma
Agenus Inc. 600
Early research (Phase 1)Ended earlyNCT03597282
What this trial is testing

A Personal Cancer Vaccine (NEO-PV-01) and APX005M or Ipilimumab With Nivolumab in Patients With Advanced Melanoma

Who this might be right for
Metastatic Melanoma
BioNTech US Inc. 22
Testing effectiveness (Phase 2)Study completedNCT03639714
What this trial is testing

A Personalized Neoantigen Cancer Vaccine

Who this might be right for
Non Small Cell Lung CancerColorectal CancerGastroesophageal Adenocarcinoma+1 more
Gritstone bio, Inc. 29
Very early researchLooking for participantsNCT06496373
What this trial is testing

Clinical Study of mRNA Vaccine Combined With PD-1 Inhibitor as Adjuvant Therapy for Postoperative Pancreatic Cancer

Who this might be right for
Pancreatic Cancer ResectableChemotherapy-intolerant
Ruijin Hospital 20
Early research (Phase 1)Active Not RecruitingNCT05743595
What this trial is testing

Neoantigen-based Personalized DNA Vaccine With Retifanlimab PD-1 Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma

Who this might be right for
Unmethylated Glioblastoma
Washington University School of Medicine 27
Very early researchNot Yet RecruitingNCT06932861
What this trial is testing

Exploratory Study of Personalized mRNA Vaccine in Patients With Refractory Rhabdomyosarcoma

Who this might be right for
Rhabdomyosarcoma
Xinxin Zhang 5
Early research (Phase 1)Looking for participantsNCT03988283
What this trial is testing

Neoepitope-based Personalized DNA Vaccine Approach in Pediatric Patients With Recurrent Central Nervous System Tumors

Who this might be right for
Pediatric Recurrent Central Nervous System Tumors
Washington University School of Medicine 7
Early research (Phase 1)Study completedNCT03674073
What this trial is testing

A Study Combining Personalized Neoantigen-based Dendritic Cell Vaccine With Microwave Ablation for the Treatment of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver Cancer, Adult
Chinese PLA General Hospital 24
Early research (Phase 1)UnknownNCT03558945
What this trial is testing

Clinical Trial on Personalized Neoantigen Vaccine for Pancreatic Tumor

Who this might be right for
Pancreatic Tumor
Anda Biopharmaceutical Development (Shenzhen) Co., Ltd. 30
Early research (Phase 1)UnknownNCT04072900
What this trial is testing

A Personalized NeoAntigen Cancer Vaccine Combined With Anti-PD-1 in Melanoma

Who this might be right for
Melanoma (Skin)
Xiangya Hospital of Central South University 30
Early research (Phase 1)Study completedNCT04105582
What this trial is testing

Breast Cancer Neoantigen Vaccination With Autologous Dendritic Cells

Who this might be right for
Breast CancerTriple Negative Breast Cancer
Universidad Nacional de Colombia 5
Early research (Phase 1)UnknownNCT05767684
What this trial is testing

Neoantigen Derived DCs as Cancer Treatment

Who this might be right for
Refractory TumorSolid Tumor
National Health Research Institutes, Taiwan 12
Early research (Phase 1)UnknownNCT05059821
What this trial is testing

Personalized Cancer Vaccine in Egyptian Cancer Patients

Who this might be right for
Hepatocellular Carcinoma
zeinab ahmed yousif hasan ashour 10
Next Page